Characteristics and hospital course of patients admitted for acute cardiovascular diseases during the coronavirus disease-19 outbreak.
Acute Disease
Aged
Aged, 80 and over
Arrhythmias, Cardiac
/ epidemiology
COVID-19
/ epidemiology
Female
Heart Failure
/ epidemiology
Hospitalization
/ statistics & numerical data
Hospitals, Teaching
Humans
Italy
/ epidemiology
Male
Middle Aged
Pandemics
ST Elevation Myocardial Infarction
/ epidemiology
Journal
Journal of cardiovascular medicine (Hagerstown, Md.)
ISSN: 1558-2035
Titre abrégé: J Cardiovasc Med (Hagerstown)
Pays: United States
ID NLM: 101259752
Informations de publication
Date de publication:
01 2021
01 2021
Historique:
pubmed:
14
11
2020
medline:
30
12
2020
entrez:
13
11
2020
Statut:
ppublish
Résumé
During the coronavirus disease-19 (COVID-19) outbreak in spring 2020, people may have been reluctant to seek medical care fearing infection. We aimed to assess the number, characteristics and in-hospital course of patients admitted for acute cardiovascular diseases during the COVID-19 outbreak. We enrolled all consecutive patients admitted urgently for acute myocardial infarction, heart failure or arrhythmias from 1 March to 31 May 2020 (outbreak period) and 2019 (control period). We evaluated the time from symptoms onset to presentation, clinical conditions at admission, length of hospitalization, in-hospital medical procedures and outcome. The combined primary end point included in-hospital death for cardiovascular causes, urgent heart transplant or discharge with a ventricular assist device. A similar number of admissions were observed in 2020 (N = 210) compared with 2019 (N = 207). Baseline characteristics of patients were also similar. In 2020, a significantly higher number of patients presented more than 6 h after symptoms onset (57 versus 38%, P < 0.001) and with signs of heart failure (33 versus 20%, P = 0.018), required urgent surgery (13 versus 5%, P = 0.004) and ventilatory support (26 versus 13%, P < 0.001). Hospitalization duration was longer in 2020 (median 10 versus 8 days, P = 0.03). The primary end point was met by 19 (9.0%) patients in 2020 versus 10 (4.8%) in 2019 (P = 0.09). Despite the similar number and types of unplanned admissions for acute cardiac conditions during the 2020 COVID-19 outbreak compared with the same period in 2019, we observed a higher number of patients presenting late after symptoms onset as well as longer and more complicated clinical courses.
Identifiants
pubmed: 33186239
doi: 10.2459/JCM.0000000000001129
pii: 01244665-202101000-00006
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
29-35Références
De Rosa S, Spaccarotella C, Basso C, et al. Società Italiana di Cardiologia, the CCU Academy Investigators Group. Reduction of hospitalizations for myocardial infarction in Italy in the COVID-19 era. Eur Heart J 2020; 41:2083–2088.
De Filippo O, D’Ascenzo F, Angelini F, et al. Reduced rate of hospital admissions for ACS during Covid-19 outbreak in northern Italy. N Engl J Med 2020; 383:88–89.
Toniolo M, Negri F, Antonutti M, Masè M, Facchin D. Unpredictable fall of severe emergent cardiovascular diseases hospital admissions during the COVID-19 pandemic: experience of a single large center in northern Italy. J Am Heart Assoc 2020; 9:e017122.
Folino AF, Zorzi A, Cernetti C, et al. Impact of COVID-19 epidemic on coronary care unit accesses for acute coronary syndrome in Veneto region, Italy. Am Heart J 2020; 226:26–28.
Migliore F, Zorzi A, Gregori D, et al. Padua School of Cardiology Network. Urgent pacemaker implantation rates in the Veneto region of Italy after the COVID-19 outbreak. Circ Arrhythm Electrophysiol 2020; 13:e008722.
Enache B, Claessens YE, Boulay F, et al. Reduction in cardiovascular emergency admissions in Monaco during the COVID-19 pandemic. Clin Res Cardiol 2020; doi:10.1007/s00392-020-01687-w. [in press].
doi: 10.1007/s00392-020-01687-w.
Rodríguez-Leor O, Cid-Álvarez B, Ojeda S, et al. On behalf of all the participants of the ACI-SEC Infarction Code Registry. Impact of the COVID-19 pandemic on interventional cardiology activity in Spain. REC Interv Cardiol 2020; 2:82–89.
Garcia S, Albaghdadi MS, Meraj PM, et al. Reduction in ST-segment elevation cardiac catheterization laboratory activations in the United States during COVID-19 pandemic. J Am Coll Cardiol 2020; 75:2871–2872.
Lantelme P, Couray Targe S, Metral P, et al. Worrying decrease in hospital admissions for myocardial infarction during the COVID-19 pandemic. Arch Cardiovasc Dis 2020; 113:443–447.
Metzler B, Siostrzonek P, Binder RK, Bauer A, Reinstadler SJ. Decline of acute coronary syndrome admissions in Austria since the outbreak of COVID-19: the pandemic response causes cardiac collateral damage. Eur Heart J 2020; 41:1852–1853.
Istitituto superiore di sanità. Characteristics of COVID-19 patients dying in Italy. 2020; Available on https://www.epicentro.iss.it/coronavirus/bollettino/Report-COVID-2019_20_marzo_eng.pdf . [Accessed 15th July 2020].
Tam CF, Cheung KS, Lam S, et al. Impact of coronavirus disease 2019 (COVID-19) outbreak on ST-segment-elevation myocardial infarction care in Hong Kong, China. Circ Cardiovasc Qual Outcomes 2020; 13:e006631.
Abdelaziz HK, Abdelrahman A, Nabi A, et al. Impact of COVID-19 pandemic on patients with ST-segment elevation myocardial infarction: insights from a British cardiac center. Am Heart J 2020; 226:45–48.
Wilson SJ, Connolly MJ, Elghamry Z, et al. Effect of the COVID-19 pandemic on ST-segment-elevation myocardial infarction presentations and in-hospital outcomes. Circ Cardiovasc Interv 2020; 13:e009438.